|
IT1288123B1
(it)
|
1996-09-04 |
1998-09-10 |
Nicox Sa |
Uso di nitroderivati per l'incontinenza urinaria
|
|
IT1303671B1
(it)
*
|
1998-07-28 |
2001-02-23 |
Nicox Sa |
Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
|
|
US6852739B1
(en)
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
|
IT1311924B1
(it)
*
|
1999-04-13 |
2002-03-20 |
Nicox Sa |
Composti farmaceutici.
|
|
JP2003523958A
(ja)
|
1999-12-23 |
2003-08-12 |
ニトロメド インコーポレーテッド |
ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法
|
|
EP1301500B1
(en)
|
2000-06-22 |
2007-11-21 |
Nitromed, Inc. |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
IT1319201B1
(it)
*
|
2000-10-12 |
2003-09-26 |
Nicox Sa |
Farmaci per il diabete.
|
|
IT1319202B1
(it)
*
|
2000-10-12 |
2003-09-26 |
Nicox Sa |
Farmaci per le malattie a base infiammatoria.
|
|
US6706724B2
(en)
|
2000-12-21 |
2004-03-16 |
Nitromed, Inc. |
Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
PT1350511E
(pt)
|
2000-12-25 |
2008-10-28 |
Ube Industries |
Composições medicinais contendo aspirina
|
|
EP1219306A1
(en)
*
|
2000-12-29 |
2002-07-03 |
Nicox S.A. |
Compositions comprising cyclodextrins and NO- releasing drugs
|
|
EP1406608B1
(en)
|
2001-05-02 |
2009-07-29 |
Nitromed, Inc. |
Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
|
|
SE0101702D0
(sv)
|
2001-05-15 |
2001-05-15 |
Ardenia Investments Ltd |
Novel potentiating compounds
|
|
ITMI20010985A1
(it)
*
|
2001-05-15 |
2002-11-15 |
Nicox Sa |
Farmaci per il morbo di alzheimer
|
|
DE10125883A1
(de)
|
2001-05-28 |
2002-12-12 |
Serumwerk Bernburg Ag |
Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
|
|
ITMI20011240A1
(it)
*
|
2001-06-13 |
2002-12-13 |
Nicox Sa |
Farmaci per le vasculopatie
|
|
ITMI20011307A1
(it)
*
|
2001-06-21 |
2002-12-21 |
Nicox Sa |
Farmaci per l'epilessia
|
|
ITMI20011744A1
(it)
*
|
2001-08-09 |
2003-02-09 |
Nicox Sa |
Farmaci per le vasculopatie
|
|
US7011854B2
(en)
|
2002-02-04 |
2006-03-14 |
Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
|
|
AU2003223491A1
(en)
*
|
2002-04-05 |
2003-10-27 |
Nitromed, Inc. |
Nitric oxide donors, compositions and methods of use
|
|
JP2005530819A
(ja)
|
2002-05-02 |
2005-10-13 |
オステオスクリーン，インコーポレイテッド |
一酸化窒素を放出するビスホスホネート結合体（ｎｏ−ビスホスホネート）を使用して骨増殖を刺激するための、方法および組成物
|
|
CA2487414A1
(en)
|
2002-06-11 |
2003-12-18 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
ITMI20021399A1
(it)
*
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Inibitori della cicloossigenasi 2
|
|
ITMI20021391A1
(it)
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Nitroderivati di inibitori della cicloossigenasi-2
|
|
ITMI20021392A1
(it)
*
|
2002-06-25 |
2003-12-29 |
Nicox Sa |
Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
|
|
WO2004002420A2
(en)
|
2002-06-28 |
2004-01-08 |
Nitromed, Inc. |
Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
|
|
EP1539729A4
(en)
|
2002-07-03 |
2008-02-20 |
Nitromed Inc |
NITROSED NON-TESTED OXIDE COMPOUNDS, COMPOSITIONS, AND APPLICATION METHODS
|
|
JP2005538110A
(ja)
|
2002-07-29 |
2005-12-15 |
ニトロメッド インコーポレーティッド |
シクロオキシゲナーゼ−２選択的阻害剤、組成物、および使用方法
|
|
AU2003254282A1
(en)
|
2002-08-01 |
2004-02-23 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
|
ITMI20021861A1
(it)
*
|
2002-08-29 |
2004-02-29 |
Nicox Sa |
Procedimento di sintesi di nitrossialchilesteri di acidi carbossilici, intermedi impiegabili in detto procedimento e loro preparazione.
|
|
WO2006066894A1
(en)
*
|
2004-12-24 |
2006-06-29 |
Ctg Pharma S.R.L. |
Compounds for treating metabolic syndrome
|
|
US7166638B2
(en)
|
2003-05-27 |
2007-01-23 |
Nicox S.A. |
Statin derivatives
|
|
US7169805B2
(en)
|
2003-05-28 |
2007-01-30 |
Nicox S.A. |
Captopril derivatives
|
|
KR20060021900A
(ko)
|
2003-06-19 |
2006-03-08 |
니콕스 에스. 에이. |
심혈관질환의 치료를 위한 ａｃｅ 저해제로서의에날라프릴-니트로옥시유도체 유도체들 및 관련화합물
|
|
JP2007500684A
(ja)
*
|
2003-07-31 |
2007-01-18 |
ニコックス エス エイ |
心臓血管疾患治療用のアンギオテンシン−ｉｉ受容体遮断薬としてのロサルタン、バルサルタン、カンデサルタン、テルミサルタン、エプロサルタンおよびオルメサルタンのニトロオキシ誘導体
|
|
PL380065A1
(pl)
*
|
2003-12-02 |
2006-12-11 |
Nicox S.A. |
Nitrooksypochodne karwedilolu i inne beta blokery jako leki przeciwko nadciśnieniu
|
|
EP1718286A4
(en)
*
|
2004-01-22 |
2010-03-31 |
Nicox Sa |
NITROSIS AND / OR NITROSYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
|
|
US7067659B2
(en)
*
|
2004-04-23 |
2006-06-27 |
Duke University |
Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
WO2006027711A2
(en)
|
2004-08-26 |
2006-03-16 |
Nicholas Piramal India Limited |
Prodrugs and codrugs containing bio- cleavable disulfide linkers
|
|
US20070122509A1
(en)
*
|
2004-12-02 |
2007-05-31 |
Molecular Research Center, Inc. |
Antioxidant dietary supplement compositions and methods for maintaining healthy skin
|
|
US9579298B2
(en)
|
2004-12-02 |
2017-02-28 |
Piotr Chomczynski |
Antioxidant dietary supplement compositions and methods for maintaining healthy skin
|
|
WO2007016677A2
(en)
*
|
2005-08-02 |
2007-02-08 |
Nitromed, Inc. |
Nitric oxide enhancing antimicrobial compounds, compositions and methods of use
|
|
WO2007137128A1
(en)
|
2006-05-19 |
2007-11-29 |
Mary Kay Inc. |
Glyceryl and glycol acid compounds
|
|
PT2057139E
(pt)
*
|
2006-07-18 |
2013-12-05 |
Antibe Holdings Inc |
Derivados de sulfureto de hidrogénio de fármacos antiinflamatórios não esteroidais
|
|
UA113841C2
(xx)
*
|
2006-07-18 |
2017-03-27 |
|
Сірководневі похідні нестероїдних протизапальних лікарських засобів
|
|
TW200831079A
(en)
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Angiotensin II receptor antagonists
|
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
BRPI0912716A2
(pt)
*
|
2008-05-13 |
2015-10-13 |
Genmedica Therapeutics Sl |
composto.
|
|
MD4009C2
(ro)
*
|
2008-07-15 |
2010-08-31 |
Институт Химии Академии Наук Молдовы |
Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
|
|
US7807716B2
(en)
*
|
2008-09-24 |
2010-10-05 |
Oral Delivery Technology Ltd. |
Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
|
|
EP2342175B1
(en)
*
|
2008-09-24 |
2015-05-27 |
Nitrogenix Inc. |
Nitric oxide releasing amino acid ester compound, composition and method of use
|
|
US9085508B2
(en)
|
2008-09-24 |
2015-07-21 |
Oral Delivery Technology Ltd. |
Nitric oxide releasing amino acid ester compound, composition and method of use
|
|
EP2194048A1
(en)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
|
AU2010224866C1
(en)
*
|
2009-03-16 |
2015-01-15 |
Genmedica Therapeutics Sl |
Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
|
|
JP2012520343A
(ja)
*
|
2009-03-16 |
2012-09-06 |
ジェンメディカ・セラピューティックス・ソシエダッド・リミターダ |
代謝障害治療のための併用療法
|
|
US9162969B2
(en)
|
2009-09-15 |
2015-10-20 |
Dsm Ip Assets B.V. |
Nitrooxyesters, their preparation and use
|
|
WO2011056561A1
(en)
|
2009-10-27 |
2011-05-12 |
Beth Israel Deaconess Medical Center |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
WO2011057386A1
(en)
*
|
2009-11-13 |
2011-05-19 |
Oral Delivery Technology Ltd. |
Composition and prophylactic device for enhancing sexual performance or pleasure
|
|
IT1397212B1
(it)
*
|
2009-12-29 |
2013-01-04 |
Flamma Spa |
Derivati di amminoalcoli e loro attivita' terapeutica
|
|
AR081268A1
(es)
|
2010-06-02 |
2012-07-18 |
Cardiolynx Ag |
Derivados de nitrato de pioglitazona
|
|
CN102442908A
(zh)
*
|
2010-10-14 |
2012-05-09 |
天津药物研究院 |
制备萘普西诺的中间体及方法
|
|
GB201020811D0
(en)
*
|
2010-12-08 |
2011-01-19 |
Solvotrin Innovations Ltd |
Compounds
|
|
US8466197B2
(en)
|
2010-12-14 |
2013-06-18 |
Genmedica Therapeutics Sl |
Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
|
|
JP5978291B2
(ja)
|
2011-04-19 |
2016-08-24 |
アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． |
一酸化炭素放出分子およびその使用
|
|
US10487114B2
(en)
|
2011-04-27 |
2019-11-26 |
Beth Israel Deaconess Medical Center, Inc. |
Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
|
|
JP6134710B2
(ja)
|
2011-07-21 |
2017-05-24 |
アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． |
一酸化ルテニウム放出分子およびその使用
|
|
CN105142400B
(zh)
|
2013-03-12 |
2018-02-13 |
玫琳凯有限公司 |
防腐体系
|
|
CA3042642A1
(en)
|
2013-08-12 |
2015-02-19 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded immediate release abuse deterrent pill
|
|
US10758552B2
(en)
*
|
2013-12-13 |
2020-09-01 |
Conaris Research Institute Ag |
Pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
|
|
WO2015095391A1
(en)
|
2013-12-17 |
2015-06-25 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
US9492444B2
(en)
|
2013-12-17 |
2016-11-15 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
JP2017509587A
(ja)
|
2013-12-27 |
2017-04-06 |
ノーバス・インターナショナル・インコーポレイテッドＮｏｖｕｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ，Ｉｎｃ． |
エトキシル化界面活性剤
|
|
EP3169315B1
(en)
|
2014-07-17 |
2020-06-24 |
Pharmaceutical Manufacturing Research Services, Inc. |
Immediate release abuse deterrent liquid fill dosage form
|
|
ES2632808T3
(es)
|
2014-09-04 |
2017-09-15 |
Nicox Science Ireland |
Compuestos de carnosina donadores de óxido nítrico
|
|
WO2016064873A1
(en)
|
2014-10-20 |
2016-04-28 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extended release abuse deterrent liquid fill dosage form
|
|
CN104478727A
(zh)
*
|
2014-12-22 |
2015-04-01 |
江西本草天工科技有限责任公司 |
一种阿魏酸释放一氧化氮的衍生物及其用途
|
|
CN105061286B
(zh)
*
|
2015-09-08 |
2017-11-24 |
上海蓝木化工有限公司 |
一种炔基取代吡咯类化合物的合成方法
|
|
US10584306B2
(en)
|
2017-08-11 |
2020-03-10 |
Board Of Regents Of The University Of Oklahoma |
Surfactant microemulsions
|
|
US11355805B2
(en)
|
2017-08-14 |
2022-06-07 |
Lg Energy Solution, Ltd. |
Battery pack having improved temperature control performance
|
|
US11564970B2
(en)
*
|
2017-10-09 |
2023-01-31 |
The Broad Institute, Inc. |
Compositions and methods for combinatorial drug discovery in nanoliter droplets
|
|
CN109942455A
(zh)
*
|
2019-03-10 |
2019-06-28 |
陕西科技大学 |
具有抗肿瘤活性的棉酚-依氟鸟氨酸席夫碱化合物及其合成方法
|
|
CN111087302B
(zh)
*
|
2019-12-23 |
2022-05-20 |
河南中医药大学 |
布洛芬阿魏酸酯的合成方法及其在制备免疫抑制药物中的应用
|
|
CN111087301B
(zh)
*
|
2019-12-23 |
2022-05-20 |
河南中医药大学 |
布洛芬咖啡酸酯的合成方法及其在制备免疫抑制药物中的应用
|
|
JP7171971B1
(ja)
*
|
2020-12-24 |
2022-11-15 |
参天製薬株式会社 |
エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物
|
|
CN115500355B
(zh)
*
|
2022-09-09 |
2024-02-09 |
广东省农业科学院果树研究所 |
利用Podophyllotoxin和Gentisic acid防治荔枝霜疫霉病
|
|
CN116375698B
(zh)
*
|
2023-06-05 |
2023-08-01 |
中国林业科学研究院林产化学工业研究所 |
具有靶向抗肿瘤活性的漆酚基异羟肟酸型hdac抑制剂及其制备方法和应用
|